Summary & Overview
HCPCS C8957: Initiation of Prolonged IV Infusion Using Portable or Implantable Pump
HCPCS Level II code C8957 represents the initiation of a prolonged intravenous infusion (more than eight hours) that requires a portable or implantable pump. This code identifies a distinct service step when patients begin extended IV therapy using pump technology, which has implications for hospital outpatient and ambulatory infusion workflows, device utilization, and payment classification across payers. Nationally, accurate use of C8957 affects care coordination, documentation practices, and billing consistency for prolonged infusions.
Key payers addressed in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a national overview of how the code is applied across typical sites of service, expected clinical contexts for prolonged pump-based infusions, and which payer policies commonly influence coverage and prior authorization requirements. The publication also outlines benchmarks for service line classification and highlights relevant policy or billing considerations that commonly affect reimbursement and coding compliance. Where input data is incomplete, the text notes unavailable items rather than speculating. The content is intended to inform coding staff, revenue cycle teams, and clinical managers about the role and operational impact of C8957 in prolonged IV therapy initiation.
Billing Code Overview
HCPCS Level II code C8957 describes an intravenous infusion for therapy or diagnosis specifically for the initiation of a prolonged infusion (more than 8 hours) that requires the use of a portable or implantable pump. This service involves beginning a continuous or extended IV infusion regimen that necessitates specialized pump equipment.
-
Service type: Prolonged intravenous infusion initiation
-
Typical site of service: Hospital outpatient infusion center, ambulatory infusion clinic, long-term care facility, or other sites capable of initiating portable or implantable pump–based prolonged IV therapy
Clinical & Coding Specifications
Clinical Context
A 62-year-old patient with advanced multiple myeloma is referred for initiation of a prolonged outpatient intravenous infusion of a chemotherapeutic agent delivered via a portable ambulatory infusion pump. The patient requires continuous infusion exceeding eight hours for either therapy or diagnostic infusion (for example, continuous low-dose chemotherapy, certain targeted agents, or prolonged antibiotic therapy for refractory infections). The workflow begins with an oncology or infusion clinic visit where therapy is ordered, eligibility and vascular access are confirmed (existing implanted port or new peripherally inserted central catheter), and patient education on pump use and home infusion safety is provided. Nursing staff program the portable or implantable pump, prime tubing, connect the infusion, and observe the patient for an initial monitoring period for infusion tolerance and potential acute reactions. After stable initiation, the patient is discharged with the pump in place for ambulatory infusion; home health or clinic follow-up is arranged for pump discontinuation, device troubleshooting, and documentation of infusion completion. Typical sites of service include hospital outpatient infusion centers, freestanding infusion clinics, and home health settings when a portable pump is used. This service is clinically indicated when medication pharmacokinetics, safety, or therapeutic protocols require continuous infusion longer than eight hours that cannot be accomplished safely with standard short-duration infusion techniques.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 |